A Phase 1 Study to Evaluate the Safety and Effects of a Single Dose of HCXT-2001 Tablets and HCXT-2001 Tablets(A) in Healthy Adults.

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The goal of this intervention study is to assess the Safety, Tolerability,Pharmacokinetics, and Immunogenicity of HCXT‐2001 Tablets and HCXT‐2001 Tablets(A) inHealthy Participants. The main parameters it aims to answer are: Does a single dose ofHCXT‐2001 Tablets and HCXT‐2001 Tablets(A) in healthy participants impact the Safety,Tolerability, Pharmacokinetics, and Immunogenicity profiles? This study will be a ‐randomized, double blind, placebo‐controlled study.
Epistemonikos ID: df7093edb1a791de9dcb0da8cf35ccc414e8d655
First added on: Aug 29, 2026